Home › Spinal Cord Injuries › NCT07397559
Spatiotemporal tSCS in Spinal Cord Injury
Spatiotemporal Control of Transcutaneous Spinal Cord Stimulation for Motor Function in SCI
Who can join
Ages 16 to 65 · All sexes
Full eligibility criteria
Inclusion Criteria: 1. Age between 16 and 65 years. 2. Have a spinal cord injury (neurological level C3-T12) that occurred ≥1 year (chronic stage) prior to enrollment. 3. American Spinal Injury Association (ASIA) Impairment Scale (AIS) classification C or D 4. Able to voluntarily contract (motor score ≥ 1) at least two leg muscles (visual or palpable contraction). 5. Use of prescription medication(s) for control of spasticity has not changed in the last 2 weeks 6. Able to provide consent 7. Ability to follow multiple instructions and communicate pain or discomfort Exclusion Criteria: 1. Progressive spinal lesions, including degenerative disorders of the spinal cord 2. Pregnant, planning to become pregnant, or currently breastfeeding 3. History of cardiopulmonary disease or cardiac symptoms 4. Implanted stimulators of any type (baclofen pump, epidural spinal stimulator, cardiac defibrillator, pace-maker, etc.) 5. Presence of orthopedic conditions that would negatively affect participation in leg exercise 6. History of autonomic dysreflexia that is severe, unstable, and/or uncontrolled 7. Unstable or significant medical conditions that can interfere with exercise or neurophysiological evaluations, such as severe neuropathic pain, depression, mood disorders, or other cognitive disorders 8. Spasms that limit the ability to participate in leg exercise activity 9. Breakdown in skin area that will be in contact with electrodes
About the study
Spinal cord injury leads to long-lasting impairment, and currently, there is no cure for paralysis. Although transcutaneous spinal cord stimulation has shown promising results in recovering lost movements, its poor selectivity in muscle recruitment compared to invasive approaches limits the type of rehabilitation exercises that can be practiced. This project studies how spatial, frequency, and amplitude control of stimulation can be used to selectively target different neural pathways and muscle groups.
What is being tested
- No Stimulation (other)
- Conventional tSCS (device)
- Spatiotemporal tSCS (device)
Sponsor: Washington University School of Medicine · Participants: 48 · Started: Jan 19, 2026
Contact the study team
- Ismael Seáñez, PhD · Phone: 314-935-7665
- Carolyn Atkinson, BS · Phone: 314-935-4530
Official record on ClinicalTrials.gov — NCT07397559
Locations in the U.S.
| Missouri | Washington University, St. Louis, St Louis |
Conditions
From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.